Nuveen, LLC Moon Lake Immunotherapeutics Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Nuveen, LLC holds 673,343 shares of MLTX stock, worth $27.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
673,343Holding current value
$27.1 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding MLTX
# of Institutions
141Shares Held
58.5MCall Options Held
129KPut Options Held
102K-
Bvf Inc San Francisco, CA19.8MShares$794 Million39.28% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$341 Million35.64% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.34MShares$134 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$111 Million2.15% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.19MShares$87.9 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.48B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...